The accessory gene regulator-1 as a therapeutic target for C. difficile infections.
a University of Texas Health Science Center, School of Public Health, Department of Epidemiology , Human Genetics, and Environmental Sciences, Center For Infectious Diseases , Houston , TX , USA.|b University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences , Microbiology and Infectious Diseases Program , Houston , TX , USA.
Charles
C
Darkoh
a University of Texas Health Science Center, School of Public Health, Department of Epidemiology , Human Genetics, and Environmental Sciences, Center For Infectious Diseases , Houston , TX , USA.|b University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences , Microbiology and Infectious Diseases Program , Houston , TX , USA.|c Baylor College of Medicine , Department of Molecular Virology and Microbiology Houston , TX , USA.
Herbert L
HL
DuPont
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology*; D016360:Clostridioides difficile / Q000187:drug effects* / Q000235:genetics; D003015:Clostridium Infections / Q000188:drug therapy* / Q000382:microbiology; D005809:Genes, Regulator; D056426:Genetic Loci; D006801:Humans
D000900:Anti-Bacterial Agents
C. difficile Agr system; C. difficile pathogenesis; C. difficile quorum sensing; C. difficile virulence; accesory genes regulator system; bacterial pathogenesis